Jože Colaric

Chief Executive Officer presso KRKA, D. D.

68 anni

Health Technology

Consumer Services

Profilo

Jože Colaric is currently the Chairman-Management Board & CEO at KRKA dd since 2005 and the Chairman & Chief Executive Officer at KRKA Farmaceutici Milano SRL since 2004.
He completed his undergraduate degree at the University of Ljubljana in 1979.

Posizioni attive di Jože Colaric

Società	Posizione	Inizio
KRKA, D. D.	Chief Executive Officer	01/01/2005
KRKA Farmaceutici Milano SRL KRKA Farmaceutici Milano SRL Pharmaceuticals: MajorHealth Technology Part of KRKA dd, KRKA Farmaceutici Milano SRL is a leading Italian generic pharmaceutical company with nearly 70 years of experience. The private company is based in Milan, Italy. We use modern technologies and our own analytical methods to develop and produce new pharmaceutical forms and strengths. Every day more than 12,000 employees work on the quality, innovation and development of pharmaceutical products. By focusing on patient needs and requirements, our innovations facilitate treatment and improve patient adherence and therapy outcomes. The company was founded in 1954. Jože Colaric has been the CEO of the company since 2004.	Chief Executive Officer	12/07/2004

Tutte le posizioni attive di Jože Colaric

Formazione di Jože Colaric

University of Ljubljana

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Jože Colaric

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
KRKA, D. D.	Health Technology

Aziende private	1
KRKA Farmaceutici Milano SRL KRKA Farmaceutici Milano SRL Pharmaceuticals: MajorHealth Technology Part of KRKA dd, KRKA Farmaceutici Milano SRL is a leading Italian generic pharmaceutical company with nearly 70 years of experience. The private company is based in Milan, Italy. We use modern technologies and our own analytical methods to develop and produce new pharmaceutical forms and strengths. Every day more than 12,000 employees work on the quality, innovation and development of pharmaceutical products. By focusing on patient needs and requirements, our innovations facilitate treatment and improve patient adherence and therapy outcomes. The company was founded in 1954. Jože Colaric has been the CEO of the company since 2004.	Health Technology